Literature DB >> 36458

The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats.

R Salzmann.   

Abstract

Disagreement in the literature about the occurrence of rebound hypertension (hypertensive overshoot) in animal models initiated this investigation. Oral doses of clonidine (0.03 mg kg-1) or guanfacine (0.3 mg kg-1) were administered twice daily during three weeks to groups of normotensive and renal hypertensive rats. Blood pressure and heart rate were measured immediately before and 3 h after the first daily dose, and compared with values obtained from placebo-treated control rats. Treatment with either drug induced large daily fluctuations rather than sustained falls in blood pressure. In the normotensive, but not in the hypertensive groups, the morning blood pressures measured before the first daily dose were significantly elevated over those of the control groups after 9 and 5 days of treatment with clonidine or guanfacine. This elevation persisted for 3 days after drug withdrawal. It is concluded that in the rat the duration of action of both drugs was short, so that twice daily administration of both drugs similarly produced large daily fluctuations rather than sustained falls in blood pressure. Blood pressure rises developed during treatment rather than after withdrawal in normotensive rats only. Therefore, this type of study does not relate well to the human situation and different experimental approaches to this problem are needed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 36458     DOI: 10.1111/j.2042-7158.1979.tb13481.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Reinforcing properties of clonidine in rhesus monkeys.

Authors:  W L Woolverton; W D Wessinger; R L Balster
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

2.  Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension.

Authors:  A J Bune; J P Chalmers; J R Graham; P R Howe; M J West; L M Wing
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  Proceedings of the British Pharmacological Society. 16--18th December, 1980.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

4.  Effect of chronic clonidine treatment on the turnover of noradrenaline and dopamine in various regions of the rat brain.

Authors:  L Rochette; A M Bralet; J Bralet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

5.  Guanfacine and clonidine: antihypertensive and withdrawal characteristics after continuous infusion and its interruption in the spontaneously hypertensive and normotensive rat.

Authors:  M J Thoolen; P B Timmermans; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

6.  Withdrawal of guanfacine after long-term treatment in essential hypertension. Observations on blood pressure and plasma and urinary noradrenaline.

Authors:  C Zamboulis; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.